Addition of pentoxifylline to pegylated interferon-alpha-2a and ribavirin improves sustained virological response to chronic hepatitis C virus: a randomized clinical trial

Addition of pentoxifylline to pegylated interferon-alpha-2a and ribavirin improves sustained virological response to chronic hepatitis C virus: a randomized clinical trial

Background and aim. The commonly accepted treatment for hepatitis C virus (HCV) infection, pegylated interferon alpha (PEG INF-alpha) and ribavirin, leads to 50–60% of sustained virological response (SVR). On the other hand, pentoxifylline (PTX) possesses antiviral and hepatoprotector properties. Ai...

Full description

Bibliographic Details
Main Authors: Miguel Ángel Jiménez-Luévano, José Manuel Lerma-Díaz, Georgina Hernández-Flores, Miguel Ángel Jiménez-Partida, Alejandro Bravo-Cuellar
Format: Article
Language:English
Published: Elsevier 2013-03-01
Series:Annals of Hepatology
Subjects:
Chronic hepatitis C virus
Pentoxifylline
Pegylated interferon-alpha-2a
Ribavirin
Sustained virological response
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119313638

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119313638

Similar Items